Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)
23.63
+0.70 (3.05%)
Feb 4, 2026, 3:00 PM CST
SHA:603139 Revenue
Shaanxi Kanghui Pharmaceutical had revenue of 108.61M CNY in the quarter ending September 30, 2025, a decrease of -21.80%. This brings the company's revenue in the last twelve months to 513.23M, down -15.21% year-over-year. In the year 2024, Shaanxi Kanghui Pharmaceutical had annual revenue of 561.63M, down -16.54%.
Revenue (ttm)
513.23M
Revenue Growth
-15.21%
P/S Ratio
4.46
Revenue / Employee
566.48K
Employees
906
Market Cap
2.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 561.63M | -111.33M | -16.54% |
| Dec 31, 2023 | 672.96M | 181.45M | 36.92% |
| Dec 31, 2022 | 491.51M | 48.75M | 11.01% |
| Dec 31, 2021 | 442.76M | 28.69M | 6.93% |
| Dec 31, 2020 | 414.07M | -17.35M | -4.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Chengdu huasun technology group Inc. , LTD. | 658.28M |
| Ginwa Enterprise (Group) | 550.44M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |
| Anhui Huangshan Capsule | 471.08M |
| Guhan Pharmaceutical Group | 351.79M |